GLP-1 receptor agonist use was associated with lower risk of developing glaucoma.GLP-1 receptor agonists may be associated with worse diabetic retinopathy or diabetic macular edema.At home monitoring for wet AMD had low accuracy compared to in-hospital testing.BMI, tobacco and alcohol use may play a role in glaucoma progression.